BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
-0.6%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$1.9B
AUM Growth
+$1.9B
Cap. Flow
+$26.4M
Cap. Flow %
1.39%
Top 10 Hldgs %
54.31%
Holding
63
New
4
Increased
4
Reduced
2
Closed
2

Top Buys

1
CLYM
Climb Bio, Inc. Common Stock
CLYM
$18.5M
2
ITOS icon
iTeos Therapeutics
ITOS
$17M
3
REPL icon
Replimune Group
REPL
$13.8M
4
CGEM icon
Cullinan Oncology
CGEM
$11.5M
5
SYRE icon
Spyre Therapeutics
SYRE
$10.5M

Top Sells

1
ATRA icon
Atara Biotherapeutics
ATRA
$33.9M
2
VKTX icon
Viking Therapeutics
VKTX
$24.6M
3
LABD icon
Direxion Daily S&P Biotech Bear 3X Shares
LABD
$2.55M
4
DBVT
DBV Technologies
DBVT
$200K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IMVT icon
26
Immunovant
IMVT
$2.56B
$21.8M 1.15%
825,000
– –
KURA icon
27
Kura Oncology
KURA
$686M
$20.6M 1.08%
1,000,000
– –
KALV icon
28
KalVista Pharmaceuticals
KALV
$678M
$18.7M 0.99%
1,590,000
– –
CLYM
29
Climb Bio, Inc. Common Stock
CLYM
$151M
$18.5M 0.97%
+2,603,190
New +$18.5M
DAWN icon
30
Day One Biopharmaceuticals
DAWN
$769M
$16.4M 0.86%
1,189,943
– –
SYRE icon
31
Spyre Therapeutics
SYRE
$996M
$16.4M 0.86%
696,480
+446,480
+179% +$10.5M
ARVN icon
32
Arvinas
ARVN
$568M
$16.2M 0.85%
608,614
– –
GPCR icon
33
Structure Therapeutics
GPCR
$1.11B
$15.7M 0.83%
400,000
– –
ELVN icon
34
Enliven Therapeutics
ELVN
$1.2B
$15.7M 0.83%
671,358
– –
PRTA icon
35
Prothena Corp
PRTA
$441M
$14.2M 0.75%
690,000
– –
REPL icon
36
Replimune Group
REPL
$422M
$13.8M 0.73%
+1,536,341
New +$13.8M
PSTX
37
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$13.1M 0.69%
4,475,000
– –
IPSC icon
38
Century Therapeutics
IPSC
$42.5M
$12.5M 0.66%
4,901,603
+3,151,603
+180% +$8.04M
ORIC icon
39
Oric Pharmaceuticals
ORIC
$994M
$12.2M 0.65%
1,732,571
– –
RLAY icon
40
Relay Therapeutics
RLAY
$619M
$11.9M 0.62%
1,819,132
– –
CGEM icon
41
Cullinan Oncology
CGEM
$445M
$11.5M 0.6%
+657,895
New +$11.5M
PRLD icon
42
Prelude Therapeutics
PRLD
$68.5M
$9.79M 0.52%
2,568,287
– –
ALLO icon
43
Allogene Therapeutics
ALLO
$251M
$8.97M 0.47%
3,850,000
– –
SANA icon
44
Sana Biotechnology
SANA
$777M
$8.44M 0.44%
1,545,000
– –
JSPR icon
45
Jasper Therapeutics
JSPR
$45.5M
$7.95M 0.42%
350,000
– –
OLMA icon
46
Olema Pharmaceuticals
OLMA
$375M
$7.03M 0.37%
+650,000
New +$7.03M
ENGN icon
47
enGene Holdings
ENGN
$236M
$6.86M 0.36%
727,900
– –
IOVA icon
48
Iovance Biotherapeutics
IOVA
$807M
$6.02M 0.32%
750,000
– –
AMLX icon
49
Amylyx Pharmaceuticals
AMLX
$836M
$2.85M 0.15%
1,500,000
– –
BOLD
50
Boundless Bio
BOLD
$25.1M
$2.75M 0.15%
711,329
– –
1
2
3